Trials Offered by a Specific Doctor

HERBERT IRVING COMPREHENSIVE CANCER CENTER
Investigator
Dr. Ran Reshef
Phone
212-342-0530
Email
rr3036@columbia.edu
(Biography not available)

Clinical Studies Managed By Dr. Reshef:
More InfoTitleSponsorIRB Number
DetailsA study for patients with lymphomas using EBV-Cytotoxic T Lymphocytes (EBV-CTLs)AtaraAAAR0039
DetailsA study for patients with chronic Graft Versus Host Disease (cGVHD) using study drug IbrutinibPharmacyclics LLC.AAAR1134